Dr. Michael J. Sundborg, MD
Claim this profileFirstHealth Outpatient Cancer Center
Studies Ovarian Cancer
Studies Ovarian Tumors
4 reported clinical trials
10 drugs studied
Area of expertise
1Ovarian Cancer
FRα positive
Stage III
Stage IV
2Ovarian Tumors
FRα positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Michael J. Sundborg, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Robotic vs Open Hysterectomy
for Cervical Cancer
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Recruiting1 award N/A8 criteria
More about Michael J. Sundborg, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael J. Sundborg, MD has experience with
- Mirvetuximab Soravtansine
- Pegylated Liposomal Doxorubicin
- Paclitaxel
- Topotecan
- AGEN2034
- AGEN1884
Breakdown of trials Michael J. Sundborg, MD has run
Cervical Cancer
Fallopian Tube Cancer
Peritoneal Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael J. Sundborg, MD specialize in?
Michael J. Sundborg, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are Stage III.
Is Michael J. Sundborg, MD currently recruiting for clinical trials?
Yes, Michael J. Sundborg, MD is currently recruiting for 2 clinical trials in Pinehurst North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Michael J. Sundborg, MD has studied deeply?
Yes, Michael J. Sundborg, MD has studied treatments such as Mirvetuximab Soravtansine, Pegylated liposomal doxorubicin, Paclitaxel.
What is the best way to schedule an appointment with Michael J. Sundborg, MD?
Apply for one of the trials that Michael J. Sundborg, MD is conducting.
What is the office address of Michael J. Sundborg, MD?
The office of Michael J. Sundborg, MD is located at: FirstHealth Outpatient Cancer Center, Pinehurst, North Carolina 28374 United States. This is the address for their practice at the FirstHealth Outpatient Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.